Chemical activators of VWA3A can initiate a cascade of intracellular events leading to the protein's activation through phosphorylation. Forskolin is one such activator that directly stimulates adenylyl cyclase, thereby increasing cyclic AMP (cAMP) levels within the cell. Elevated cAMP activates protein kinase A (PKA), which can then phosphorylate VWA3A. This cascade exemplifies a classic second messenger system where the initial signal (forskolin) is amplified to produce a significant biological effect (activation of VWA3A). Similarly, dibutyryl-cAMP, a cell-permeable cAMP analog, bypasses the cell's receptor-mediated signal transduction and directly activates PKA, which subsequently leads to the phosphorylation and activation of VWA3A.
Further amplifying the range of mechanisms by which VWA3A can be activated are chemicals that alter intracellular calcium levels. Ionomycin, as a calcium ionophore, selectively binds and transports Ca2+ ions across cell membranes, increasing intracellular calcium concentration. This rise in calcium can activate calmodulin-dependent protein kinases, which are capable of phosphorylating VWA3A. Thapsigargin operates by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), causing a sustained increase in cytosolic calcium which again can lead to VWA3A activation. A23187, another calcium ionophore, and BAY K8644, an L-type calcium channel activator, also elevate intracellular calcium levels, potentially resulting in the activation of VWA3A through similar calcium-mediated phosphorylation pathways. Additionally, direct activators of protein kinases play a significant role in the phosphorylation of VWA3A. Phorbol 12-myristate 13-acetate (PMA) and related phorbol esters, along with 12-O-Tetradecanoylphorbol-13-acetate (TPA), activate protein kinase C (PKC), which phosphorylates VWA3A. This activation by PKC represents a lipid-dependent pathway that regulates VWA3A activity. On the other hand, compounds like okadaic acid and calyculin A inhibit protein phosphatases 1 and 2A, enzymes responsible for dephosphorylating proteins. By inhibiting these phosphatases, these chemicals prevent the dephosphorylation of VWA3A, thereby maintaining its phosphorylated, active state. Anisomycin, which activates stress-activated protein kinases, also contributes to the phosphorylation status of VWA3A, albeit through a stress-induced pathway that might involve the activation of secondary signaling cascades.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as an ionophore and selectively binds to Ca2+. It increases intracellular calcium, which can activate calmodulin-dependent protein kinases (CaMK). CaMK can then phosphorylate VWA3A, leading to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can lead to phosphorylation of VWA3A, thereby activating the protein. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), causing an increase in cytosolic calcium levels, which can result in the activation of calcium-dependent proteins and potentially lead to the activation of VWA3A. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels in cells. This inhibition could maintain VWA3A in a phosphorylated and hence activated state by preventing its dephosphorylation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, calyculin A is an inhibitor of protein phosphatases 1 and 2A. It would contribute to the activation of VWA3A by preventing dephosphorylation, maintaining the protein in an activated state. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable analog of cAMP that activates PKA. PKA can phosphorylate VWA3A, leading to its activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, potentially leading to the activation of calcium-dependent kinases which would then activate VWA3A by phosphorylation. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
BAY K8644 is an L-type calcium channel activator which increases intracellular calcium, potentially leading to the activation of VWA3A through calcium-dependent phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs/JNKs), which may phosphorylate VWA3A, thus activating it. | ||||||